Developing an instrument (promise) to identify patient related outcomes in medication reviews

被引:0
|
作者
Schoenmakers, T. [1 ,2 ]
Teichert, M. [2 ,3 ]
Wensing, M. [2 ]
De Smet, P. [2 ,4 ]
机构
[1] Zorgapotheek Nederland BV, Utrecht, Netherlands
[2] Radboud UMC, IQ Healthcare, Nijmegen, Netherlands
[3] Royal Dutch Pharmacists Assoc KNMP, The Hague, Netherlands
[4] Radboud UMC, Clin Pharm, Nijmegen, Netherlands
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CP-PC007
引用
收藏
页码:482 / 482
页数:1
相关论文
共 50 条
  • [21] Impact of medication reconciliation on health outcomes: An overview of systematic reviews
    Guisado-Gil, A. B.
    Mejias-Trueba, M.
    Alfaro-Lara, E. R.
    Sanchez-Hidalgo, M.
    Ramirez-Duque, N.
    Santos-Rubio, M. D.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (08): : 995 - 1002
  • [22] Medication Regimen Adherence and Patient Outcomes
    Redberg, Rita F.
    JAMA INTERNAL MEDICINE, 2014, 174 (02) : 193 - 193
  • [23] PATIENT MEDICATION COMPLIANCE IN A DEVELOPING-COUNTRY
    YORK, P
    MATERU, NLB
    JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1980, 5 (04): : 307 - 310
  • [24] The value of domiciliary medication reviews: a thematic analysis of patient views
    McCormick, Patricia
    Coleman, Bridget
    Bates, Ian
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (06) : 1594 - 1601
  • [25] Developing an instrument to evaluate suffering related to care
    Nordman, Tina
    Santavirta, Nina
    Eriksson, Katie
    SCANDINAVIAN JOURNAL OF CARING SCIENCES, 2008, 22 (04) : 608 - 615
  • [26] The value of domiciliary medication reviews: a thematic analysis of patient views
    Patricia McCormick
    Bridget Coleman
    Ian Bates
    International Journal of Clinical Pharmacy, 2021, 43 : 1594 - 1601
  • [27] The Diabetes Medication Satisfaction Tool (DMSAT): Development and validation of a new patient-centered outcomes instrument for clinicians
    Anderson, R. T.
    Balkrishnan, R.
    VALUE IN HEALTH, 2007, 10 (06) : A279 - A279
  • [28] Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials
    Richard B. Lipton
    Larry Charleston
    Cristina Tassorelli
    Thomas Brevig
    Joe Hirman
    Roger Cady
    The Journal of Headache and Pain, 2022, 23
  • [29] Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials
    Lipton, Richard B.
    Charleston, Larry
    Tassorelli, Cristina
    Brevig, Thomas
    Hirman, Joe
    Cady, Roger
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [30] Using the readability assessment instrument to evaluate patient medication leaflets
    Kirkpatrick, MAE
    DRUG INFORMATION JOURNAL, 1999, 33 (02): : 557 - 563